Astatine Radiopharmaceuticals: Prospects and Problems

Por Vaidyanathan, Ganesan, Zalutsky, Michael R.
Publicado em 2008

Applications of (211)At and (223)Ra in Targeted Alpha-Particle Radiotherapy

Por Vaidyanathan, Ganesan, Zalutsky, Michael R.
Publicado em 2011

Astatine-211: Production and Availability

Por Zalutsky, Michael R., Pruszynski, Marek
Publicado em 2011

Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 4: Strategies for (211)At Labeling at High Activities and Radiation Doses of (211)At α-Particles

Por Pozzi, Oscar R., Zalutsky, Michael R.
Publicado no Nucl Med Biol (2016)

Preparation of Rh[16aneS(4)-diol](211) At and Ir[16aneS(4)-diol](211) At Complexes as Potential Precursors for Astatine Radiopharmaceuticals. Part I: Synthesis

Por Pruszyński, Marek, Bilewicz, Aleksander, Zalutsky, Michael R.
Publicado em 2008

Propargyl 4-[(18)F]fluorobenzoate: A Putatively More Stable Prosthetic group for the Fluorine-18 Labeling of Biomolecules via Click Chemistry

Por Vaidyanathan, Ganesan, White, Benjamin J., Zalutsky, Michael R.
Publicado em 2009

A model for optimizing delivery of targeted radionuclide therapies into resection cavity margins for the treatment of primary brain cancers

Por Raghavan, Raghu, Howell, Roger W, Zalutsky, Michael R
Publicado no Biomed Phys Eng Express (2017)

Labeling Internalizing Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibody with (177)Lu: In Vitro Comparison of Acyclic and Macrocyclic Ligands

Por Hens, Marc, Vaidyanathan, Ganesan, Welsh, Phil, Zalutsky, Michael R.
Publicado em 2009

Stability and in vivo behavior of Rh[16aneS(4)-diol](211)At complex: a potential precursor for astatine radiopharmaceuticals

Por Pruszynski, Marek, Łyczko, Monika, Bilewicz, Aleksander, Zalutsky, Michael R.
Publicado no Nucl Med Biol (2014)

Targeted Radiotherapy: Microgray Doses and the Bystander Effect

Por Mairs, Robert J., Fullerton, Natasha E., Zalutsky, Michael R., Boyd, Marie
Publicado em 2007

In situ growth of a PEG-like polymer from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulation

Por Gao, Weiping, Liu, Wenge, Christensen, Trine, Zalutsky, Michael R., Chilkoti, Ashutosh
Publicado em 2010

A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([(18)F]EF5)

Por Chitneni, Satish K., Bida, Gerald T., Dewhirst, Mark W., Zalutsky, Michael R.
Publicado em 2012

Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models

Por Chitneni, Satish K., Bida, Gerald T., Zalutsky, Michael R., Dewhirst, Mark W.
Publicado no J Nucl Med (2014)

D-amino acid peptide residualizing agents bearing N-hydroxysuccinimido-and maleimido- functional groups and their application for trastuzumab radioiodination

Por Pruszynski, Marek, Koumarianou, Eftychia, Vaidyanathan, Ganesan, Chitneni, Satish, Zalutsky, Michael R.
Publicado no Nucl Med Biol (2014)

Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets

Por Slastnikova, Tatiana A., Rosenkranz, Andrey A., Zalutsky, Michael R., Sobolev, Alexander S.
Publicado no Curr Pharm Des (2015)

Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)(2) fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK

Por Vaidyanathan, Ganesan, Jestin, Emmanuelle, Olafsen, Tove, Wu, Anna M., Zalutsky, Michael R.
Publicado em 2009

An Alternative and Expedient Synthesis of Radioiodinated 4-Iodophenylalanine

Por Vaidyanathan, Ganesan, McDougald, Darryl, Grasfeder, Linda, Zalutsky, Michael R., Chin, Bennett
Publicado em 2011

Molecular Imaging of Hypoxia

Por Chitneni, Satish K., Palmer, Gregory M., Zalutsky, Michael R., Dewhirst, Mark W.
Publicado em 2011

Astatine-211 Labeled Anti-HER2 5F7 Single Domain Antibody Fragment Conjugates: Radiolabeling and Preliminary Evaluation

Por Choi, Jaeyeon, Vaidyanathan, Ganesan, Koumarianou, Eftychia, Kang, Choong Mo, Zalutsky, Michael R.
Publicado no Nucl Med Biol (2017)

Anti-EGFRvIII monoclonal antibody armed with (177)Lu: in vivo comparison of macrocyclic and acyclic ligands

Por Hens, Marc, Vaidyanathan, Ganesan, Zhao, Xiao-Guang, Bigner, Darell D., Zalutsky, Michael R.
Publicado em 2010